0
0
11/21/23 at 4:05pm
Organization
Newswise
35 words
0
Comments
Immunotherapy using modified chimeric antigen receptor (CAR) T cells has greatly improved survival rates for relapsed and recurrent pediatric leukemia and lymph
You are the first to view
https://www.newswise.com/articles/promising-target-for-car-t-cells-helps-cancer-trick-the-immune-system
Create an account
or login to join the discussion